Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionBogart Wealth, LLC
Latest Disclosed Ownership16,995 shares
Latest Disclosed Value $ 5,979,560
Bogart Wealth, LLC reports 1.23% increase in ownership of AMGN / Amgen Inc.

On April 28, 2026 - Bogart Wealth, LLC filed a 13F-HR form disclosing ownership of 16,995 shares of Amgen Inc. (MX:AMGN) valued at $5,979,560 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 16,789 shares of Amgen Inc.. This represents a change in shares of 1.23% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-28 2026-03-31 13F AMGEN INC COM Stock 031162100 16,995 206 1.23 5,980 8.81 0.2304
2026-01-30 2025-12-31 13F AMGEN INC COM Stock 031162100 16,789 -310 -1.81 5,495 13.89 0.2205
2025-10-27 2025-09-30 13F AMGEN INC COM Stock 031162100 17,099 -4,211 -19.76 4,825 -18.89 0.1957
2025-07-30 2025-06-30 13F AMGEN INC COM Stock 031162100 21,310 576 2.78 5,950 -7.90 0.2541
2025-05-02 2025-03-31 13F AMGEN INC COM Stock 031162100 20,734 621 3.09 6,460 23.22 0.3048
2025-01-30 2024-12-31 13F AMGEN INC COM Stock 031162100 20,113 74 0.37 5,242 -18.80 0.2486
2024-10-23 2024-09-30 13F AMGEN INC COM Stock 031162100 20,039 -40 -0.20 6,457 2.92 0.3056
2024-07-31 2024-06-30 13F AMGEN INC COM Stock 031162100 20,079 -813 -3.89 6,274 5.61 0.3194
2024-04-25 2024-03-31 13F AMGEN INC COM Stock 031162100 20,892 873 4.36 5,940 3.04 0.3056
2024-02-07 2023-12-31 13F AMGEN INC COM Stock 031162100 20,019 -76 -0.38 5,766 6.76 0.3253
2023-10-30 2023-09-30 13F AMGEN INC COM Stock 031162100 20,095 -10,966 -35.30 5,401 -21.69 0.3336
2023-07-31 2023-06-30 13F AMGEN INC COM Stock 031162100 31,061 7,323 30.85 6,896 20.18 0.4371
2023-04-21 2023-03-31 13F AMGEN INC COM Stock 031162100 23,738 3,005 14.49 5,739 5.38 0.3831
2023-02-06 2022-12-31 13F AMGEN INC COM Stock 031162100 20,733 -819 -3.80 5,445 12.08 0.3791
2022-11-03 2022-09-30 13F AMGEN INC COM Stock 031162100 21,552 3,360 18.47 4,858 9.76 0.4055
2022-07-22 2022-06-30 13F AMGEN INC COM Stock 031162100 18,192 2,766 17.93 4,426 18.66 0.3883
2022-04-22 2022-03-31 13F AMGEN INC COM Stock 031162100 15,426 2,442 18.81 3,730 27.70 0.3190
2022-01-19 2021-12-31 13F AMGEN INC COM Stock 031162100 12,984 1,777 15.86 2,921 22.58 0.2638
2021-10-15 2021-09-30 13F AMGEN INC COM Stock 031162100 11,207 2,852 34.14 2,383 16.99 0.2426
2021-08-06 2021-06-30 13F AMGEN INC COM Stock 031162100 8,355 -4,062 -32.71 2,037 -34.08 0.2226
2021-04-16 2021-03-31 13F AMGEN INC COM Stock 031162100 12,417 3,658 41.76 3,090 53.43 0.4304
2021-01-14 2020-12-31 13F AMGEN INC COM Stock 031162100 8,759 1,405 19.11 2,014 7.76 0.3738
2020-10-06 2020-09-30 13F AMGEN INC COM Stock 031162100 7,354 543 7.97 1,869 16.38 0.4148
2020-07-08 2020-06-30 13F AMGEN INC COM Stock 031162100 6,811 703 11.51 1,606 29.73 0.3774
2020-04-20 2020-03-31 13F AMGEN INC COM Stock 031162100 6,108 716 13.28 1,238 -4.77 0.3376
2020-02-10 2019-12-31 13F AMGEN INC COM Stock 031162100 5,392 123 2.33 1,300 27.45 0.4153
2019-11-06 2019-09-30 13F/A-1 AMGEN INC COM Stock 031162100 5,269 221 4.38 1,020 9.68 0.5019
2019-10-10 2019-09-30 13F AMGEN INC COM Stock 031162100 5,269 221 1,020 0.4696
2019-07-11 2019-06-30 13F AMGEN INC COM Stock 031162100 5,048 257 5.36 930 2.20 0.5620
2019-04-08 2019-03-31 13F AMGEN INC COM Stock 031162100 4,791 429 9.83 910 7.18 0.4390
2019-01-15 2018-12-31 13F AMGEN INC COM Stock 031162100 4,362 247 6.00 849 -0.47 0.4237
2018-10-16 2018-09-30 13F AMGEN INC COM Stock 031162100 4,115 188 4.79 853 17.66 0.4939
2018-07-13 2018-06-30 13F AMGEN INC COM Stock 031162100 3,927 155 4.11 725 11.71 0.4409
2018-04-12 2018-03-31 13F AMGEN INC COM Stock 031162100 3,772 613 19.40 649 18.21 0.3752
2018-01-10 2017-12-31 13F AMGEN INC COM Stock 031162100 3,159 -29 -0.91 549 -7.11 0.3519
2017-10-12 2017-09-30 13F AMGEN INC COM Stock 031162100 3,188 7 0.22 591 7.85 0.4372
2017-09-19 2017-06-30 13F AMGEN INC COM Stock 031162100 3,181 385 13.77 548 19.39 0.3514
2017-09-19 2017-03-31 13F AMGEN INC COM Stock 031162100 2,796 2,796 459 0.3053
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.